Position in FLNA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$2,930
-$503 QoQ
Shares Held
1,734
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in FLNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,238,289,073 across 287 Biotechnology names. FLNA ranks #267 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in FLNA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,930 | 1,734 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,433 | 1,734 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,045 | 1,734 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,138 | 1,734 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $88,437 | 58,958 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $136,476 | 57,829 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $1,652,700 | 56,157 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $731,848 | 59,259 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,155,251 | 56,937 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,262,856 | 56,102 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $944,303 | 56,749 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,397,664 | 57,001 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,267,578 | 52,553 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,529,344 | 51,772 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,149,840 | 51,407 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,315,509 | 46,782 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,528,088 | 41,144 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,700,541 | 38,914 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,510,825 | 40,445 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,400,682 | 39,802 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $2,042,438 | 45,438 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $231,811 | 33,990 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $264,108 | 22,946 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $67,830 | 22,023 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||